ASH position paper: Hypertension in pregnancy

Marshall D. Lindheimer, Sandra J Taler, F. Gary Cunningham

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Hypertension complicates 5% to 7% of all pregnancies. A subset of preeclampsia, characterized by new-onset hypertension, proteinuria, and multisystem involvement, is responsible for substantial maternal and fetal morbidity and is a marker for future cardiac and metabolic disease. This American Society of Hypertension, Inc (ASH) position paper summarizes the clinical spectrum of hypertension in pregnancy, focusing on preeclampsia. Recent research breakthroughs relating to etiology are briefly reviewed. Topics include classification of the different forms of hypertension during pregnancy, status of the tests available to predict preeclampsia, and strategies to prevent preeclampsia and to manage this serious disease. The use of antihypertensive drugs in pregnancy, and the prevention and treatment of the convulsive phase of preeclampsia, eclampsia, with intravenous magnesium sulfate is also highlighted. Of special note, this guideline article, specifically requested, reviewed, and accepted by ASH, includes solicited review advice from the American College of Obstetricians and Gynecologists.

Original languageEnglish (US)
Pages (from-to)214-225
Number of pages12
JournalJournal of Clinical Hypertension
Volume11
Issue number4
DOIs
StatePublished - 2009

Fingerprint

Pre-Eclampsia
Hypertension
Pregnancy
Pregnancy Tests
Magnesium Sulfate
Eclampsia
Metabolic Diseases
Proteinuria
Antihypertensive Agents
Heart Diseases
Mothers
Guidelines
Morbidity
Research

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

ASH position paper : Hypertension in pregnancy. / Lindheimer, Marshall D.; Taler, Sandra J; Cunningham, F. Gary.

In: Journal of Clinical Hypertension, Vol. 11, No. 4, 2009, p. 214-225.

Research output: Contribution to journalArticle

Lindheimer, Marshall D. ; Taler, Sandra J ; Cunningham, F. Gary. / ASH position paper : Hypertension in pregnancy. In: Journal of Clinical Hypertension. 2009 ; Vol. 11, No. 4. pp. 214-225.
@article{bc142c7e9c38497a8abd2e3ec67e04d3,
title = "ASH position paper: Hypertension in pregnancy",
abstract = "Hypertension complicates 5{\%} to 7{\%} of all pregnancies. A subset of preeclampsia, characterized by new-onset hypertension, proteinuria, and multisystem involvement, is responsible for substantial maternal and fetal morbidity and is a marker for future cardiac and metabolic disease. This American Society of Hypertension, Inc (ASH) position paper summarizes the clinical spectrum of hypertension in pregnancy, focusing on preeclampsia. Recent research breakthroughs relating to etiology are briefly reviewed. Topics include classification of the different forms of hypertension during pregnancy, status of the tests available to predict preeclampsia, and strategies to prevent preeclampsia and to manage this serious disease. The use of antihypertensive drugs in pregnancy, and the prevention and treatment of the convulsive phase of preeclampsia, eclampsia, with intravenous magnesium sulfate is also highlighted. Of special note, this guideline article, specifically requested, reviewed, and accepted by ASH, includes solicited review advice from the American College of Obstetricians and Gynecologists.",
author = "Lindheimer, {Marshall D.} and Taler, {Sandra J} and Cunningham, {F. Gary}",
year = "2009",
doi = "10.1111/j.1751-7176.2009.00085.x",
language = "English (US)",
volume = "11",
pages = "214--225",
journal = "Journal of Clinical Hypertension",
issn = "1524-6175",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - ASH position paper

T2 - Hypertension in pregnancy

AU - Lindheimer, Marshall D.

AU - Taler, Sandra J

AU - Cunningham, F. Gary

PY - 2009

Y1 - 2009

N2 - Hypertension complicates 5% to 7% of all pregnancies. A subset of preeclampsia, characterized by new-onset hypertension, proteinuria, and multisystem involvement, is responsible for substantial maternal and fetal morbidity and is a marker for future cardiac and metabolic disease. This American Society of Hypertension, Inc (ASH) position paper summarizes the clinical spectrum of hypertension in pregnancy, focusing on preeclampsia. Recent research breakthroughs relating to etiology are briefly reviewed. Topics include classification of the different forms of hypertension during pregnancy, status of the tests available to predict preeclampsia, and strategies to prevent preeclampsia and to manage this serious disease. The use of antihypertensive drugs in pregnancy, and the prevention and treatment of the convulsive phase of preeclampsia, eclampsia, with intravenous magnesium sulfate is also highlighted. Of special note, this guideline article, specifically requested, reviewed, and accepted by ASH, includes solicited review advice from the American College of Obstetricians and Gynecologists.

AB - Hypertension complicates 5% to 7% of all pregnancies. A subset of preeclampsia, characterized by new-onset hypertension, proteinuria, and multisystem involvement, is responsible for substantial maternal and fetal morbidity and is a marker for future cardiac and metabolic disease. This American Society of Hypertension, Inc (ASH) position paper summarizes the clinical spectrum of hypertension in pregnancy, focusing on preeclampsia. Recent research breakthroughs relating to etiology are briefly reviewed. Topics include classification of the different forms of hypertension during pregnancy, status of the tests available to predict preeclampsia, and strategies to prevent preeclampsia and to manage this serious disease. The use of antihypertensive drugs in pregnancy, and the prevention and treatment of the convulsive phase of preeclampsia, eclampsia, with intravenous magnesium sulfate is also highlighted. Of special note, this guideline article, specifically requested, reviewed, and accepted by ASH, includes solicited review advice from the American College of Obstetricians and Gynecologists.

UR - http://www.scopus.com/inward/record.url?scp=65449152603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449152603&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7176.2009.00085.x

DO - 10.1111/j.1751-7176.2009.00085.x

M3 - Article

C2 - 19614806

AN - SCOPUS:65449152603

VL - 11

SP - 214

EP - 225

JO - Journal of Clinical Hypertension

JF - Journal of Clinical Hypertension

SN - 1524-6175

IS - 4

ER -